Evidence map›Paper›PMID 41978383›Full record

ArticleBriefings in bioinformatics2026

BCRInsight: an antibody language model to decode biological signals from BCR sequences.

Hailong Zhao, Shang Lou, Xuhua Li, Yiyang Gao, Wenjing Cao, Hongcang Gu, Fan Zhang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hailong ZhaoAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.
Shang LouAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.
Xuhua LiAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.
Yiyang GaoHIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang Province 150080, China.
Wenjing CaoAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.
Hongcang GuAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.
Fan ZhangAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui Province 230031, China.ORCID 0000-0002-4627-7019

Funding

Anhui Provincial Natural Science Foundation 2408085J017CASHIPS SeedKey Science & Technology Project of Anhui ProvinceNoncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0520100
6 · The paper itself

Abstract

The B-cell receptor (BCR) repertoire encodes not only antigen-binding specificity but also intrinsic signatures reflecting B-cell functional states and differentiation trajectories. Deciphering the intricate sequence semantics embedded within these repertoires is pivotal for elucidating immune dynamics and expediting antibody discovery. Although single-cell sequencing provides high-resolution insights, its scalability and cost remain major obstacles, leaving population-level repertoire data underexploited. Furthermore, conventional bioinformatics approaches struggle to model the high-order, non-linear semantic dependencies inherent in antibody sequences. To address these challenges, we present BCRInsight, an antibody-specific pretrained language model that integrates a Transformer architecture with phenotype-aware contrastive learning. Pretrained on 80 million human BCR sequences, BCRInsight learns biologically meaningful contextual representations that encode subtle signatures of B-cell activation, maturation, and clonal evolution. Extensive benchmarking demonstrates that BCRInsight achieves state-of-the-art performance across multiple downstream tasks, particularly in paratope prediction. Further evaluation on diverse single-cell immune cohorts, including healthy, neoplastic, and viral infection states, reveals cross-scenario robustness and superior generalization relative to existing methods. Notably, attention-based analyses show that high-attention regions correspond closely to physical antigen-contact residues, highlighting emergent structural interpretability derived solely from self-supervised learning. Collectively, BCRInsight establishes a new paradigm for decoding the "language" of antibodies, offering a scalable and interpretable framework for computational immunology and rational antibody engineering.

Indexed as

AntibodiesComputational BiologyReceptors, Antigen, B-CellB-LymphocytesHumansImmunoinformaticsRepresentation Machine LearningAntibodiesReceptors, Antigen, B-Cellantibody language modelB-cell receptorcontrastive learning

Identifiers

PMID41978383
PMCPMC13076941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.